Erratum: FOXO1-mediated activation of akt plays a critical role in vascular homeostasis (Circ Res. (2014) 15 (238-251) DOI: 10.1161/CIRCRESAHA.115.303227);FOXO1-mediated activation of akt plays a critical role in vascular homeostasis

Circulation Research

Volumn 115, Issue 2, 2014, Pages 238-251

  Dharaneeswaran, Harita ^a   Abid, Md Ruhul ^a   Yuan, Lei ^a   Dupuis, Dylan ^a   Beeler, David ^a   Spokes, Katherine C ^a   Janes, Lauren ^a   Sciuto, Tracey ^a   Kang, Peter M ^a   Jaminet, Shou Ching S ^a   Dvorak, Ann ^a   Grant, Marianne A ^a   Regan, Erzsébet Ravasz ^a   Aird, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

angiogenesis; endothelial cells; FoxO1 protein; human; mice; transcription factors; transgenic

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; VASCULOTROPIN; AKT1 PROTEIN, MOUSE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; FOXO1 PROTEIN, MOUSE; FOXO3 PROTEIN, HUMAN; HYBRID PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; NOS3 PROTEIN, HUMAN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CAPILLARY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DEATH; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FEEDBACK SYSTEM; HEART FAILURE; HOMEOSTASIS; HUMAN; HUMAN CELL; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; BIOSYNTHESIS; DEFICIENCY; ENZYME INDUCTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; YOLK SAC;

ANIMALS; ENDOTHELIAL CELLS; ENZYME INDUCTION; FORKHEAD TRANSCRIPTION FACTORS; HEART FAILURE; HOMEOSTASIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; YOLK SAC;

EID: 84904054218     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0000000000000029     Document Type: Erratum

References (44)

1. Carter ME, Brunet A. Foxo transcription factors. Curr Biol. 2007;i7:Rii3-Rii4.
2. Huang H, Tindall DJ. Dynamic Foxo transcription factors. J Cell Sci. 2007;i20:2479-2487. (Pubitemid 47323857)
3. van der Horst A, Burgering BM. Stressing the role of Foxo proteins in lifespan and disease. Nat Rev Mol Cell Biol. 2007;8:440-450. (Pubitemid 46809159)
4. Arden KC. Foxo animal models reveal a variety of diverse roles for Foxo transcription factors. Oncogene. 2008;27:2345-2350. (Pubitemid 351501785)
5. Ho KK, Myatt SS, Lam EW. Many forks in the path: cycling with Foxo. oncogene. 2008;27:2300-23ii. (Pubitemid 351501781)
6. Accili D, Arden KC. Foxos at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;ii7:42i-426. (Pubitemid 38610228)
7. Sengupta A, Molkentin JD, Paik JH, DePinho RA, Yutzey KE. Foxo transcription factors promote cardiomyocyte survival upon induction of oxida-tive stress. J Biol Chem. 2011;286:7468-7478.
8. Sandri M. Foxophagy path to inducing stress resistance and cell survival. Nat Cell Biol. 2012;i4:786-788.
9. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 2003;30i:2i5-2i8. (Pubitemid 36858475)
10. Hosaka T, Biggs WH III, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC. Disruption of forkhead transcription factor (Foxo) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004;i0i:2975-2980. (Pubitemid 38327721)
11. Furuyama T, Kitayama K, Shimoda Y, ogawa M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S, Nakayama K, Ikeda K, Motoyama N, Mori N. Abnormal angiogenesis in Foxoi (Fkhr)-deficient mice. J Biol Chem. 2004;279:3474i-34749. (Pubitemid 39318105)
12. Furuyama T, Nakazawa T, Nakano I, Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-i6 homologues. Biochem J. 2000;349:629-634. (Pubitemid 30465799)
13. Evans-Anderson HJ, Alfieri CM, Yutzey KE. Regulation of cardiomyocyte proliferation and myocardial growth during development by Foxo transcription factors. Circ Res. 2008;102:686-694. (Pubitemid 351457856)
14. Paik JH, Kollipara R, Chu G, et al. Foxos are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;i28:309-323. (Pubitemid 46123514)
15. Tanaka J, Qiang L, Banks AS, Welch CL, Matsumoto M, Kitamura T, Ido-Kitamura Y, DePinho RA, Accili D. Foxoi links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes. 2009;58:2344-2354.
16. Sengupta A, Chakraborty S, Paik J, Yutzey KE, Evans-Anderson HJ. Foxoi is required in endothelial but not myocardial cell lineages during cardiovascular development. Dev Dyn. 2012;24i:803-8i3.
17. Tsuchiya K, Tanaka J, Shuiqing Y, Welch CL, DePinho RA, Tabas I, Tall AR, Goldberg IJ, Accili D. Foxos integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 2012;i5:372-38i.
18. Rached MT, Kode A, xu L, Yoshikawa Y, Paik JH, Depinho RA, Kousteni S. Foxoi is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010;ii:i47-i60.
19. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxoi in liver. Cell Metab. 2007;6:208-2i6. (Pubitemid 47336849)
20. Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM. Foxoi links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol. 2009;i0:i76-i84.
21. Poche RA, Sharma R, Garcia MD, Wada AM, Nolte MJ, Udan RS, Paik JH, DePinho RA, Bartlett JD, Dickinson ME. Transcription factor Foxoi is essential for enamel biomineralization. PLoS one. 2012;7:e30357.
22. Yuan L, Janes L, Beeler D, Spokes KC, Smith J, Li D, Jaminet SC, oettgen P, Aird WC. Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium. Blood. 20i3;i2i:4404-44i2.
23. Abid MR, Shih SC, otu HH, Spokes KC, okada Y, Curiel DT, Minami T, Aird WC. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J Biol Chem. 2006;28i:35544-35553. (Pubitemid 46043252)
24. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest. 2005;ii5:2382-2392. (Pubitemid 41266200)
25. okada Y, Yano K, Jin E, Funahashi N, Kitayama M, Doi T, Spokes K, Beeler DL, Shih SC, okada H, Danilov TA, Maynard E, Minami T, oettgen P, Aird WC. A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium. Circ Res. 2007;i00:i7i2-i722. (Pubitemid 46987863)
26. Yano K, Liaw PC, Mullington JM, Shih SC, okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203:i447-i458. (Pubitemid 43877607)
27. Abid MR, Nadeau RJ, Spokes KC, Minami T, Li D, Shih SC, Aird WC. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28:2042-2048.
28. Yano K, Gale D, Massberg S, Cheruvu PK, Monahan-Earley R, Morgan ES, Haig D, von Andrian UH, Dvorak AM, Aird WC. Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood. 2007;i09:6i3-6i5. (Pubitemid 46105960)
29. Tang Y, Harrington A, Yang X, Friesel RE, Liaw L. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis. 2010;48:563-567.
30. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997;94:3058-3063. (Pubitemid 27157263)
31. Zhang K, Li L, Qi Y, Zhu x, Gan B, DePinho RA, Averitt T, Guo S. Hepatic suppression of Foxoi and Foxo3 causes hypoglycemia and hyper-lipidemia in mice. Endocrinology. 2012;i53:63i-646.
32. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mToR and its downstream targets S6Ki and 4EBPi/eIF4E. Genes Dev. 2002;i6:i472-i487. (Pubitemid 34686329)
33. Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, Tonic I, Park Y, Hay N. Foxos inhibit mToRCi and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev Cell. 2010;i8:592-604.
34. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD, Kuro-o M, Rothermel BA, Hill JA. Foxo transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci U S A. 2007;i04:205i7-20522.
35. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor Foxoi in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest. 2006;ii6:2464-2472. (Pubitemid 44330145)
36. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell. 2007;i2:487-502. (Pubitemid 46523652)
37. McLennan R, Kulesa PM. Neuropilin-i interacts with the second branchial arch microenvironment to mediate chick neural crest cell dynamics. Dev Dyn. 2010;239:1664-i673.
38. McLennan R, Teddy JM, Kasemeier-Kulesa JC, Romine MH, Kulesa PM. Vascular endothelial growth factor (VEGF) regulates cranial neural crest migration in vivo. Dev Biol. 2010;339:ii4-i25.
39. Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A. Arginine methylation of Foxo transcription factors inhibits their phosphorylation by Akt. Mol Cell. 2008;32:22i-23i.
40. Milkiewicz M, Roudier E, Doyle JL, Trifonova A, Birot o, Haas TL. Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor Foxoi in cultured endothelial cells and ischemic muscle. Am J Pathol. 2011;i78:935-944.
41. Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, Barnett J, Leslie NR, Cheng S, Shepherd PR, Gout I, Downes CP, Lamb RF. The TSCi-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol. 2004;166:2i3-223. (Pubitemid 38988774)
42. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles ho-molog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300:i574-i577. (Pubitemid 36682889)
43. Jacinto E, Loewith R, Schmidt A, Lin S, Riiegg MA, Hall A, Hall MN. Mammalian ToR complex 2 controls the actin cytoskeleton and is ra-pamycin insensitive. Nat Cell Biol. 2004;6:ii22-ii28. (Pubitemid 39468014)
44. Corcelle EA, Puustinen P, Jaattela M. Apoptosis and autophagy: targeting autophagy signalling in cancer cells-'trick or treats' FEBS J. 2009;276:6084-6096.